Originally published In Press as doi:10.1074/jbc.M004071200 on May 26, 2000
J. Biol. Chem., Vol. 275, Issue 35, 27094-27099, September 1, 2000
A Conserved Negatively Charged Cluster in the Active Site of
Creatine Kinase Is Critical for Enzymatic Activity*
Michael
Eder,
Martin
Stolz
,
Theo
Wallimann, and
Uwe
Schlattner§
From the Institute of Cell Biology, Swiss Federal Institute of
Technology Zürich, Hönggerberg,
CH-8093 Zürich, Switzerland
Received for publication, May 12, 2000
 |
ABSTRACT |
Creatine kinase catalyzes the reversible
transphosphorylation of creatine by MgATP. From the sequence homology
and the molecular structure of creatine kinase isoenzymes, we have
identified several highly conserved residues with a potential function
in the active site: a negatively charged cluster
(Glu226, Glu227, Asp228) and
a serine (Ser280). Mutant proteins E226Q, E226L,
E227Q, E227L, D228N, and S280A/S280D of human sarcomeric mitochondrial
creatine kinase were generated by in vitro mutagenesis,
expressed in Escherichia coli, and purified to homogeneity.
Their overall structural integrity was confirmed by CD spectroscopy and
gel filtration chromatography. The enzymatic activity of all proteins
mutated in the negatively charged cluster was extremely low
(0.002-0.4% of wild type) and showed apparent Michaelis constants
(Km) similar to wild type, suggesting that most of
the residual activity may be attributed to wild-type revertants.
Mutations of Ser280 led to higher residual activities and
altered Km values; S280A showed an increase of
Km for phosphocreatine (65-fold), creatine
(6-fold), and ATP (6-fold); S280D showed a decrease of Km for creatine (6-fold). These results, together
with the transition state structure of the homologous arginine kinase (Zhou, G., Somasundaram, T., Blanc, E., Parthasarathy G., Ellington, W. R., and Chapman, M. S. (1998) Proc. Natl. Acad. Sci.
U. S. A. 95, 8449-8454), strongly suggest a critical
role of Glu226, Glu227, and Asp228
in substrate binding and catalysis and point to Glu227 as a
catalytic base.
 |
INTRODUCTION |
Creatine kinase (CK;1 EC
2.7.3.2) catalyzes the interconversion of phosphocreatine (PCr) and ADP
with ATP and creatine (Cr). The enzyme occurs as a family of
tissue-specific isoenzymes, comprising dimeric cytosolic CK (MM-, MB-,
and BB-CK) and mainly octameric mitochondrial CK (sMtCK and uMtCK),
which can dissociate into dimers. These CK isoenzymes, together with
easily diffusable Cr and PCr, maintain a unique cellular energy buffer
and energy transport system, the CK/PCr circuit (for reviews see Refs.
1 and 2). Thus, the CK system plays a key role in energy metabolism of
cells and tissues with high or fluctuating energy requirements like muscle or brain. Lately, the molecular structures of all four homo-oligomeric CK isoenzymes have been solved (3-6), as well as the
transition state structure of monomeric arginine kinase (AK) from
horseshoe crab (7). Both CK and AK belong to the larger guanidino
kinase family. These new data allow a fresh look on amino acid residues
with a critical role in substrate binding and catalysis.
The catalytic mechanism of CK has been studied extensively by numerous
different techniques, yielding detailed information on kinetic and
mechanistic aspects of the transphosphorylation reaction (8). It
has been well documented that the
-phosphoryl group is transferred
via an associative in-line mechanism (9-11). At pH 8 and above, the CK
reaction follows a rapid equilibrium random mechanism in both
directions (12), whereas at pH 7, the kinetic mechanism is random only
in the reverse direction (ATP synthesis) and equilibrium ordered, with
ATP adding before Cr, in the forward direction (PCr synthesis) (13). By
contrast, our knowledge about specific amino acid residues involved in
substrate binding and catalysis is scarce. Especially the guanidino
substrate-binding site of CK has not yet been characterized, because of
the lack of specific mutants or a CK crystal structure containing
creatine. Mutation of the highly reactive cysteine 278 (sMtCK
numbering) and tryptophan 223 located near the active site led to
severely decreased enzymatic activity (14, 15). C278 was implicated in
substrate synergism (14) and may interact with the creatine substrate
(7). Several arginines were identified to interact electrostatically
with the negatively charged phosphate groups of the nucleotide (16).
From earlier work, a histidine residue was proposed to act as an acid
base catalyst in the transphosphorylation reaction (17). However,
recent site-directed mutagenesis experiments (18, 19), as well as the
AK structure (7), have clearly demonstrated that none of the conserved
histidines is able to provide this function. It was speculated that CK
might act as a "conzyme" without catalytic residue by just bringing
the substrates into a close, favorable alignment (20). Alternatively,
other residues may be involved to draw away partial positive charge from the reactive guanidinium-N
2 or even to
act as a catalytic base. From the AK transition state structure, two
glutamates were proposed as new candidates for acid base catalysis (7).
In analogy to ATP hydrolysis at the myosin motor domain (21), also the
-phosphate of ATP itself could act as a catalytic base, assisted by
a serine that participates in hydrogen exchange by providing an
energetically favorable geometry.
In the present study, we have analyzed the available sequence and
structural information for CK and AK to look for residues with a
putative role in the active site of CK. Using site-directed mutagenesis
with the recently characterized human sMtCK isoenzyme (22), we could
identify four highly conserved residues, including a negatively charged
cluster and a serine residue, which are critical for substrate binding
and catalytic mechanism.
 |
EXPERIMENTAL PROCEDURES |
Site-directed Mutagenesis by Inverse Polymerase Chain
Reaction--
The sequence of mature human sMtCK
(GenBankTM J05401) has been cloned into a
pET-derived expression vector (22, 23). Site-directed mutagenesis by
inverse polymerase chain reaction was carried out on a Hybaid Omn-E
Thermal Cycler (MWG-Biotech, Münchenstein, Switzerland), using 10 ng of double-stranded DNA (entire plasmid vector), 15 pmol of each
oligonucleotide primer, and Pfu DNA polymerase (Stratagene,
Zürich, Switzerland). The latter was added to the reaction
mixture at 95 °C ("hot start") followed by 30 polymerase chain
reaction cycles (95 °C, 0.5 min; 55 °C, 0.5 min; 72 °C, 6.5 min). All primers were 5'-phosphorylated for subsequent circularization
of gel-purified polymerase chain reaction products with T4-DNA ligase.
Plasmids were transformed into competent E. coli XL-1 blue
using routine procedures (24) and sequenced with the dideoxy chain
termination method (25) to verify in vitro mutagenesis and
the absence of random mutations. Mutagenic primers (mismatches with the
template are underlined): E226Q (huMib676E1;
5'-CAGGAGGATCACACCAGGGT-3', huMib654R1;
5'-ATTTATCCAGATGAGAAATGTC-3'); E226L (huMib676E2;
5'-CTGGAGGATCACACCAGGGTA-3', huMib654R1); E227Q (huMib676E3;
5'-GAGCAGGATCACACCAGGGTAATC-3',
huMib654R1); E227L (huMib676E4;
5'-GAGCTGGATCACACCAGGGTAATC-3', huMib654R1); D228N (huMib682D1; 5'-AATCACACCAGGGTAATCTCA-3',
huMib661R2; 5'-CTCCTCATTTATCCAGATGAG-3'); D228L
(huMib682D2; 5'-CTTCACACCAGGGTAATCTCAA-3',
huMib661R2); S280D (huMib838S1;
5'-GATAACCTTGGAACAGGACTACG-3', huMib817R3; 5'-AGGACAGGTCAAAATGTATCC-3'); S280A (huMib838S2;
5'-GCGAACCTTGGAACAGGACT-3', huMib817R3).
Protein Expression and Purification--
Selected transformants
of E. coli BL21(DE3)pLysS were grown at 37 °C in 2YT
medium. Heterologous expression of sMtCK, induced at about 1 A600 by the addition of 0.4 mM isopropyl-
-D-thiogalactopyranoside, was
continued for about 5 h. Soluble protein was extracted from bacterial pellets by sonication under the addition of 2 µl of Benzonase to digest nucleic acids. sMtCK was precipitated from lysate
supernatant at an ammonium sulfate saturation of 33% (pH 6.5),
resuspended in 20 mM Tris/HCl buffer (pH 9.0; 0.2 mM EDTA, 2 mM
-mercaptoethanol), and
dialyzed overnight against resuspension buffer. sMtCK was further
purified by high pressure liquid chromatography with the strong cation
exchanger Poros HQ (4.6 × 100-mm column, PerSeptive Biosystems,
Rotkreuz, Switzerland), equilibrated with HQ buffer (12 mM
bis-Tris propane, 12 mM Tris/HCl, 0.2 mM EDTA, 2 mM
-mercaptoethanol, pH 9.0). sMtCK eluted in a linear
NaCl gradient at about 100 mM salt, and peak fractions were
pooled and concentrated with Centricon-30 (Millipore,Volketswil,
Switzerland) to about 4 mg/ml protein. Final purification by gel
filtration chromatography involved a HiPrep Sephacryl S-300 HR 16/60
column (Amersham Pharmacia Biotech) and was equilibrated and run
with gel filtration buffer (50 mM sodium phosphate,
pH 7.0, 2 mM
-mercaptoethanol, 0.2 mM EDTA,
and 150 mM NaCl) at a flow rate of 0.4 ml/min. The purification process, as monitored by standard 12% SDS-polyacrylamide gel electrophoresis, yielded over 99% pure mutant sMtCKs. Protein concentration was determined according to Bradford (26), using bovine
serum albumin as a standard.
Enzyme Kinetics--
CK activity and kinetic constants were
determined with a coupled enzyme photometric assay modified after
Wallimann et al. (27). ATP production (reverse reaction) was
coupled by hexokinase (300 units/ml) and glucose-6-phosphate
dehydrogenase (150 units/ml) to NADPH production, using 4 mM ADP, 5 mM MgCl2, 40 mM PCr, 40 mM D-glucose, and 1 mM NADP in 0.1 M triethanolamine buffer, pH 7.0. The production of PCr (forward reaction) was coupled by pyruvate kinase (160 units/ml) and lactate dehydrogenase (800 units/ml) to NADH
oxidation, using 4 mM ATP, 4.5 mM
magnesium-acetate, 20 mM creatine, 0.9 mM
P-enolpyruvate, and 0.45 mM NADH in 0.1 M triethanolamine buffer, pH 8.0. Changes in the redox state of pyrimidine nucleotides were followed at 340 nm in a UNICAM UV4 (Unicam,
Cambridge, UK) spectrophotometer thermostated at 25 °C. All
substrates and enzymes for activity measurements were from Roche
Diagnostics (Basel, Switzerland). Like in previous studies, the pH of
standard reactions was chosen according to established pH optima (28).
In addition, the pH dependence of enzymatic activity was determined
with pH buffer (50 mM bis-Tris propane and 50 mM Tris, adjusted from pH 6 to 9) together with saturating activities of coupling enzymes. Apparent Michaelis-Menten constants (Km) were determined by varying six to seven
different concentrations of each substrate at a fixed, saturating
concentration of the second substrate, always keeping the ratio
Mg2+/nucleotide constant. Calculation of kinetic constants
was performed by least squares fitting of the
substrate-dependent reaction velocities to the
Michaelis-Menten equation.
Oligomeric State--
Quantitation of octameric and dimeric
sMtCK by gel filtration chromatography and dissociation of sMtCK
octamers by incubation with transition state analog complex (TSAC (9))
was carried out as described in Ref. 22.
CD Spectroscopy--
Far and near UV CD spectra of human sMtCK
wild-type and mutant protein were recorded on a JASCO J-715 dichrograph
(Jasco, Great Dunmow, UK) at 25 °C and under constant nitrogen flow,
using a quartz cell with a 1-cm optical path. sMtCK in 25 mM sodium phosphate (pH 6.75) was diluted in this buffer to
about 0.2 mg/ml and sterile-filtered.
 |
RESULTS |
Choice of Residues with a Putative Role in the Active Site of
CK--
Two highly conserved portions of the CK sequence (homology
blocks 3 and 4 (30)) comprise large parts of the putative active site
(3) and most residues involved in substrate binding or catalysis
(e.g. Cys278 (14) or Trp223 (15),
sMtCK numbering). The only negatively charged amino acids in this
region form a cluster (Glu226, Glu227, and
Asp228) that is conserved among all creatine kinases, and
even across the larger guanidino kinase family (30). It is located near the
-phosphate of enzyme-bound ATP in chicken sMtCK (Fig.
1 (3)) and may be well positioned for
coordinating Mg2+ or binding guanidino substrates. The
Glu227 homologue of AK directly interacts with the
guanidino group (7). Another highly conserved residue,
Ser280, which is conservatively replaced by threonine in
some guanidino kinases (30), has close contact to the
-phosphate of
ATP and the "reactive" active site cysteine 278 (Fig. 1 (3)). It
would be a good candidate for facilitating proton transfer during
catalysis (21).

View larger version (69K):
[in this window]
[in a new window]
|
Fig. 1.
Location of mutated residues in the sMtCK
structure. Ribbon representation of the three-dimensional fold of
a chicken sMtCK monomer (PDB code 1crk (3)). ATP, which
marks the active site of CK, and amino acids mutated in this work
(Glu226, Glu227, Asp228, and
Ser280) are shown in a ball-and-stick representation with
standard CPK colors (figure prepared with WebLabViewer V.3.1, MSI, San
Diego, CA).
|
|
Mutagenesis, Expression, and Purification of Mutant
Protein--
Single amino acid replacement mutants of human sMtCK were
generated by site-directed mutagenesis and validated by DNA sequencing. Glu226, Glu227, and Asp228 were
substituted with either their corresponding amides (E226Q, E227Q, and
D228N) or aliphatic amino acids (E226L, E227L, and D228L).
Ser280 was replaced by aspartate or alanine (S280D, S280A).
Except for D228L, all mutants could be expressed in E. coli
as soluble proteins. Because they did not bind to Blue Sepharose resin
like wild-type MtCK, we used their low solubility at pH 6.5 for a
quantitative precipitation at 33% ammonium sulfate saturation. This
led to a substantial enrichment of 70-80% of total protein as judged from standard SDS-polyacrylamide gel electrophoresis (data not shown).
Further purification by ion exchange and gel filtration chromatography
yielded about 20-30 mg of homogeneous mutant protein/liter of
bacterial culture, which is slightly less than for the wild-type enzyme.
Structural Integrity of Mutant sMtCK--
All purified sMtCK
mutant proteins remained soluble and enzymatically active after storage
at 4 °C, suggesting that stability and proper folding were not
significantly affected. Far UV CD spectra of all mutants were
superimposable to those of wild-type enzyme, confirming the overall
structural integrity (Fig.
2A). CD spectra in the near UV
range (
240 nm, Fig. 2B) revealed, except for the mutation
S280D, only small differences to the wild-type enzyme with a
conservation of the Cotton band pattern characteristic for CK (15).
Hence, changes in the microenvironment of aromatic residues were
neglectably small and probably because of minor conformational
alterations introduced by the charge shift mutations. The octamer
content of mutant proteins at 0.1 mg/ml protein was at least 81%
(Table I). This is comparable to
wild-type protein,2
indicating that the mutations had no severe effect on the oligomeric state either.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 2.
CD spectral patterns of wild type and mutant
sMtCK. (A) Far UV and (B) near UV CD spectra
were taken with 0.2 mg/ml protein in 25 mM sodium phosphate
(pH 6.75) and corrected with buffer spectra. Arrows in
B indicate Cotton bands characteristic for CK at 275, 281, 288, and 300 nm. Note that mutant S280D was unstable under the chosen
low ionic strength buffer conditions and was slowly denaturing during
the measurement.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
TSAC-induced octamer dissociation of human sMtCK mutants
Relative octamer content of sMtCK before and after TSAC incubation for
72 h at room temperature as determined from gel filtration elution
profiles. Protein concentrations were adjusted to 0.1 mg/ml in 50 mM potassium-phosphate, 150 mM NaCl, pH 7.0.
|
|
Enzyme Kinetic Parameters of Mutant sMtCK--
Enzymatic
activities and kinetic parameters for wild-type and mutant enzymes were
determined in the forward reaction (PCr production) at pH 8.0, as well
as in the reverse reaction (ATP production) at pH 7.0 by a coupled
enzyme assay. E226Q, E226L, E227Q, E227L exhibited residual catalytic
activities as small as 0.002-0.036% of wild-type activity in the
forward as well as in the reverse reaction (Table
II). Residual enzymatic activities of
D228N and S280D were higher but still extremely low as compared with
wild-type human sMtCK (0.10-0.46% of wild-type activity). S280A
showed the highest residual activities, especially in the reverse
reaction (1.1-6.0% of wild-type activity). We could exclude that
mutations of the acidic residues shifted the pH optimum of the CK
reaction, because none of the mutant proteins showed significantly increased residual activity at other pH values than those used for the
standard protocol (data not shown). Apparent Michaelis-Menten parameters (Km) of each mutant were determined for
all substrates (Table III). Mutations of
anionic residues led to Km values comparable to
wild-type (only Km for PCr, if any, was somewhat
higher). By contrast, S280A showed a 65-fold increase of
Km (PCr), together with a 6-fold increase of
Km (Cr) and Km (MgATP), whereas
S280D revealed a decrease of Km (Cr). Because
mutation of anionic residues may potentially alter the complexation of
cations, we also varied the Mg2+ concentration at fixed
nucleotide concentrations. There was no difference in
Mg2+ dependence as compared with wild-type protein,
thus excluding a Mg2+ limitation in our assays (data not
shown). Exact dissociation constants of the binary complexes
(Kd) could not be determined, because nonsaturating
concentrations of both substrates gave residual activities at or below
the detection limit of the assay system.
View this table:
[in this window]
[in a new window]
|
Table II
Specific enzyme activities of human sMtCK mutants
Specific enzyme activities are averaged from at least three independent
measurements, using a coupled enzyme assay (22). wt, wild-type.
|
|
View this table:
[in this window]
[in a new window]
|
Table III
Enzyme kinetic constants of human sMtCK mutants
The initial rates were determined using a coupled enzyme assay (22).
Kinetic constants were calculated by fitting the data from at least
three independent measurements to the Michaelis-Menten equation.
|
|
Octamer Dissociation of Mutant sMtCK--
MtCK octamers are known
to dissociate rapidly into dimers upon the addition of substrates that
form a TSAC (29, 31). This is because of large conformational
changes induced by the binding of TSAC compounds (32) weakening MtCK
dimer-dimer interactions. We found that the susceptibility of octameric
mutant sMtCK for TSAC-induced dissociation was severely reduced,
especially in the case of E227Q and E227L (Table I). Either these
mutants have a decreased affinity for TSAC substrates or bound TSAC is
unable to induce the necessary conformational changes (2).
 |
DISCUSSION |
Using a site-directed mutagenesis approach, we have identified
four residues in the active site pocket of human sMtCK that are
important for substrate binding and catalysis: Glu226,
Glu227, Asp228, and Ser280 (sMtCK
numbering). Mutation of these residues yielded proteins with
dramatically reduced enzymatic activities (mostly between 0.002 and
0.4% of wild-type), together with a well conserved overall protein
structure. The latter is indicated by identical binding properties to
anion exchange columns, stability at 4 °C, nearly indistinguishable
near and far UV CD spectra, and proper octamer formation. The residual
enzymatic activity of the CK mutants could not be improved by elevating
Mg2+ concentrations or varying the pH in the applied assay.
We can therefore exclude subsaturating cation binding or a shift in pH optimum as responsible for the strongly reduced enzymatic activities, such as was observed in certain cysteine mutants (14).
Mutations of glutamate residues Glu226 and
Glu227 in the negatively charged cluster showed the most
striking decrease of enzymatic activity by 4-5 orders of magnitude,
yielding almost inactive enzymes. Turnover numbers of aspartate mutant
D228N were an order of magnitude higher but still heavily reduced
compared with wild-type (see Table II). These very low residual
enzymatic activities of recombinant MtCK may result from molecules that
have fortuitously restored the correct wild-type residue by error
during protein synthesis (20, 33). Although we have minimized such
misincorporation by avoiding rare E. coli codons in our
mutagenic primers, the basic translational error rate in E. coli (2 × 10
2 to 2 × 10
3/codon) is further increased under the burden of
heterologous protein expression (33, 34) and could account
for residual enzymatic activities as high as 0.2% of wild type. For
comparison, mutants of the "active site" tryptophan 223 and
cysteine 278 showed much higher residual activities in the order of
0.5-4% and 2-5% at optimal pH, respectively (14, 15). Mutations of
Ser280 also yielded a more active enzyme, especially with
S280A (1.1-6% of wild-type). Earlier, it was speculated that
mutations near or at the active site of CK do not necessarily
obliterate catalysis, and that CK is therefore a "robust" enzyme
(35). Our data clearly establish that this is not the case and strongly
suggest a critical role of Glu226, Glu227, and
Asp228 in substrate binding and/or catalysis of CK.
Altered substrate binding is at least one consequence of the mutations
that we have introduced. This is clearly indicated by the very weak
binding of mutant proteins to Blue Sepharose resin, which mimics a
nucleotide-like substrate, and their poor octamer dissociation upon the
addition of TSAC compounds. On the other hand, apparent
Michaelis-Menten parameters (Km) of mutations in the
negatively charged cluster were unchanged compared with wild-type. This
observation, however, may reflect the contribution of wild-type
revertants to the very low residual activity of these preparations. The
situation is entirely different for serine mutants. Here, higher
residual enzymatic activities and apparent Km values
different from wild-type confirm the presence of a partially active
mutant protein. In addition, the changes in apparent
Km were dependent on the replacing amino acid;
Km increased for MgATP, Cr, and PCr in S280A but
decreased for Cr in S280D.
The recently reported transition state structure of AK (7) allows a
more subtle functional analysis of the mutated CK residues. Because the
overall three-dimensional fold of AK follows closely that of all known
CK structures (3-6) and residues in the active site are highly
conserved (5, 7, 30), it is very likely that all guanidino kinases
share a similar reaction mechanism. The AK transition state structure
shows that the Glu226 and Asp228 homologues
have no direct contact with substrates but provide important hydrogen
bonds that finally lead to substrate binding and alignment.
Glu226 is hydrogen-bonded to two water molecules, which are
part of the octahedral coordination sphere of the essential magnesium ion (Fig. 3). Mg2+ is further
ligated with a third water molecule and the oxygen of the
-,
-,
and
-phosphate of ATP. However, hydrogen bonding alone cannot be the
only function of Glu226 in CK, because substitution with
the equally sized glutamine, also able to form the hydrogen bonds,
resulted in a virtually inactive enzyme. Possibly, at some stage of the
domain movements induced by the binding of magnesium nucleotide (32),
the negatively charged glutamate interacts directly with
Mg2+.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 3.
The active site of arginine kinase in the
presence of transition state analog complex components. Stereo
view representation of AK with TSAC (MgADP + NO3
+ arginine; PDB code 1bg0 (7)), showing
the TSAC components (yellow label) and the amino acid
homologues of CK residues mutated in this work (red
label) with residues 224-226 (AK) corresponding to the
negatively charged cluster 226-228 (human sMtCK) and
Thr273 (AK) conservatively replacing Ser280
(human sMtCK). The reactive cysteine 278 (human sMtCK) is located at AK
position 271 (white label). Several water molecules in close
proximity to the substrates are drawn in blue. Distance
monitors are shown in green (figure prepared with
SwissPDB-Viewer V.3.1 and POVRAY V.3.02).
|
|
The AK homologue of Asp228 forms a dense hydrogen bond
network at the active site (Fig. 3), which links the negatively charged cluster 226-228 to a loop region containing the homologue of cysteine Cys278. In AK, this cysteine interacts with the nonreactive
guanidyl N
1 and is not only important for
substrate binding but also enhances catalytic activity by positioning
the guanidinium group and drawing a partial positive charge away from
the reactive N
2 atom (7). This may explain
the failure to obtain native D228L protein, because the aliphatic amino
acid at this position is unable to form hydrogen bonds and may cause a
critical perturbation of the enzyme fold. In mutant D228N, although
capable of providing hydrogen bonds, a distortion of local geometry, as
well as the change in the electrostatic environment at the active site,
could explain the lack of activity.
The third residue in the negatively charged cluster,
Glu227, is most probably in direct contact with the
substrate guanidinium. The AK homologue of Glu227 locks the
guanidinium group in an optimal position for phosphoryl transfer (Fig.
3). Moreover, it draws away a partial positive charge from the
substrate guanidinium group to increase the nucleophilicity of the
reacting N
2 atom. A failure to correctly
position the guanidino group could also account for the pronounced
inability of octameric Glu227 mutant protein to dissociate
into dimers upon TSAC addition. A correct alignment of TSAC compounds
is likely to be essential for triggering the conformational changes
that lead to octamer dissociation. For AK, two glutamates were proposed
as candidates for acid base catalysis, including the homologue of
Glu227 (7). The properties of Glu227 mutations
in CK are fully consistent with such a function.
Ser280 is conservatively replaced by Thr273 (AK
numbering) in the transition state structure of AK (Fig. 3). However,
this residue is not adequately positioned to facilitate an intrinsic
proton transfer as proposed. By contrast, Thr273 is in
hydrogen bond distance (3.0 Å) to the AK homologue of
Cys278, which in turn is 3.3 Å away from the substrate
guanidinium (7). In analogy, Ser280 may also fix the
relative orientation of the thiol group of Cys278. This is
consistent with the low Km of S280D for creatine, because the additional negative charge of aspartate at this location may attract the positively charged guanidinium group during initial binding. However, one has to consider also the less stable protein structure of S280D as seen with near UV CD spectra and octamer formation. The increased Km of S280A for different
substrates is not obvious from the AK structure.
Taken together, we have identified several key residues in the active
site of CK. Based on properties of mutant proteins and the recently
published transition state structure of AK (7), we could also deduce
the putative functions of these amino acids. Our study clearly
demonstrates that even residues that are not found in direct contact
with the substrates can contribute to efficient catalysis. CK obviously
uses a complicated network of interactions with several residues
involved rather than a single, catalytic residue. Overall geometry and
charge distribution at the active site may be sufficient to achieve the
high turnover rates of guanidino kinases through perfect alignment of
both substrates and an optimal electrostatic environment for the
transphosphorylation reaction. The AK transition state structure (7)
suggests a multifaceted catalytic mechanism of guanidino kinases,
including restriction of freedom of the substrates (36), orbital
steering (37), strain toward the transition state, partial charge
withdrawing, and possibly also acid base catalysis. For the latter
function, based on the AK structure (7), our data propose
Glu227 as the most likely candidate. A multidisciplinary
approach, combining structural biology, biophysics, and biochemistry
will be necessary to finally reveal the exact catalytic mechanism of
guanidino kinases at a molecular level.
 |
ACKNOWLEDGEMENTS |
We thank Dr. W. Kabsch and all members of the
Wallimann group, especially D. Neumann, for helpful suggestions and
discussions as well as Drs. A. W. Strauss and Z. Khuchua for
providing human sMtCK cDNA.
 |
FOOTNOTES |
*
This work was supported by the Swiss Federal Institute of
Technology, Zürich (graduate student grant to M. E.)
and by Grant 3100-5082.97 from the Swiss National Science Foundation
(to T. W. and U. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Central Laboratory, Wankdorfstrasse 10, CH-3000
Bern 22, Switzerland.
§
To whom correspondence should be addressed. Tel.: 41-1-633 33 92;
Fax: 41-1-633 10 69; E-mail: schlattn@cell.biol.ethz.ch.
Published, JBC Papers in Press, May 26, 2000, DOI 10.1074/jbc.M004071200
2
U. Schlattner and T. Wallimann, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
CK, creatine kinase;
PCr, phosphocreatine;
Cr, creatine;
AK, arginine kinase;
uMtCK and
sMtCK, ubiquitous and sarcomeric mitochondrial CK, respectively;
bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol;
TSAC, transition state analog complex.
 |
REFERENCES |
| 1.
|
Wallimann, T.,
Wyss, M.,
Brdicka, D.,
Nicolay, K.,
and Eppenberger, H. M.
(1992)
Biochem. J.
281,
21-40
|
| 2.
|
Schlattner, U.,
Forstner, M.,
Eder, M.,
Stachowiak, O.,
Fritz-Wolf, K.,
and Wallimann, T.
(1998)
Mol. Cell. Biochem.
184,
125-140
|
| 3.
|
Fritz-Wolf, K.,
Schnyder, T.,
Wallimann, T.,
and Kabsch, W.
(1996)
Nature
381,
341-345
|
| 4.
|
Rao, J. K.,
Bujacz, G.,
and Wlodawer, A.
(1998)
FEBS Lett.
439,
133-137
|
| 5.
|
Eder, M.,
Schlattner, U.,
Becker, A.,
Wallimann, T.,
Kabsch, W.,
and Fritz-Wolf, K.
(1999)
Prot. Sci.
8,
2258-2269
|
| 6.
|
Eder, M.,
Fritz-Wolf, K.,
Kabsch, W.,
Wallimann, T.,
and Schlattner, U.
(1999)
Proteins
39,
216-225
|
| 7.
|
Zhou, G.,
Somasundaram, T.,
Blanc, E.,
Parthasarathy, G.,
Ellington, W. R.,
and Chapman, M. S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
8449-8454
|
| 8.
|
Kenyon, G. L.,
and Reed, G. H.
(1983)
Adv. Enzymol.
54,
367-426
|
| 9.
|
Milner-White, E. J.,
and Watts, D. C.
(1971)
Biochem. J.
122,
727-740
|
| 10.
|
McLaughlin, A. C.,
Cohn, M.,
and Kenyon, G. L.
(1972)
J. Biol. Chem.
247,
4382-4388
|
| 11.
|
Hansen, D. E.,
and Knowles, J. R.
(1981)
J. Biol. Chem.
256,
5967-5969
|
| 12.
|
Morrison, J. F.,
and Cleland, W. W.
(1966)
J. Biol. Chem.
241,
673-683
|
| 13.
|
Schimerlik, M. I.,
and Cleland, W. W.
(1973)
J. Biol. Chem.
248,
8418-8423
|
| 14.
|
Furter, R.,
Furter-Graves, E. M.,
and Wallimann, T.
(1993)
Biochemistry
32,
7022-7029
|
| 15.
|
Gross, M.,
Furter-Graves, E. M.,
Wallimann, T.,
Eppenberger, H. M.,
and Furter, R.
(1994)
Prot. Sci.
3,
1058-1068
|
| 16.
|
Wood, T. D.,
Guan, Z.,
Borders, C. L., Jr.,
Chen, L. H.,
Kenyon, G. M.,
and Lafferty, F. W.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
3362-3365
|
| 17.
|
Cook, P. F.,
Kenyon, G. L.,
and Cleland, W. W.
(1981)
Biochemistry
20,
1204-1210
|
| 18.
|
Chen, L. H.,
Borders, C. L., Jr.,
Vasquez, J. R.,
and Kenyon, G. L.
(1996)
Biochemistry
35,
7895-7902
|
| 19.
|
Forstner, M.,
Müller, A.,
Stolz, M.,
and Wallimann, T.
(1997)
Prot. Sci.
6,
331-339
|
| 20.
|
Stroud, R. M.
(1996)
Nat. Struct. Biol.
3,
567-569
|
| 21.
|
Fisher, A. J.,
Smith, C. A.,
Thoden, J. B.,
Smith, R.,
Sutoh, K.,
Holden, H. M.,
and Rayment, I.
(1995)
Biochemistry
34,
8960-8972
|
| 22.
|
Schlattner, U.,
and Wallimann, T.
(2000)
J. Biol. Chem.
275,
17314-17320
|
| 23.
|
Furter, R.,
Kaldis, P.,
Furter-Graves, E.,
Schnyder, T.,
Eppenberger, H. M.,
and Wallimann, T.
(1992)
Biochem. J.
288,
771-775
|
| 24.
|
Seidman, C. E.,
Struhl, K.,
Sheen, J.,
and Jensen, T.
(1997)
in
Current Protocols in Molecular Biology
(Ausubel, F. M.
, Brent, R.
, Kingston, R. E.
, Moore, D. D.
, Seidman, J. G.
, Smith, J. A.
, and Struhl, K., eds), Vol. 1
, pp. 1.8.1-1.8.3, John Wiley and Sons, Inc., New York
|
| 25.
|
Sanger, F.,
Nicklen, S.,
and Coulson, A. R.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5463-5467
|
| 26.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
|
| 27.
|
Wallimann, T.,
Turner, D. C.,
and Eppenberger, H. M.
(1977)
J. Cell Biol.
75,
297-317
|
| 28.
|
Wyss, M.,
Smeitink, J.,
Wevers, R. A.,
and Wallimann, T.
(1992)
Biochim. Biophys. Acta
1102,
119-166
|
| 29.
|
Gross, M.,
and Wallimann, T.
(1993)
Biochemistry
32,
13933-13940
|
| 30.
|
Mühlebach, S. M.,
Gross, M.,
Wirz, T.,
Wallimann, T.,
Perriard, J.-C.,
and Wyss, M.
(1994)
Mol. Cell. Biochem.
133/134,
245-262
|
| 31.
|
Marcillat, O.,
Goldschmidt, D.,
Eichenberger, D.,
and Vial, C.
(1987)
Biochim. Biophys. Acta
890,
233-241
|
| 32.
|
Forstner, M.,
Kriechbaum, M.,
Laggner, P.,
and Wallimann, T.
(1998)
Biophys. J.
75,
1016-1023
|
| 33.
|
Rosenberger, R. F.
(1994)
Dev. Biol. Stand.
83,
21-26
|
| 34.
|
Scorer, C. A.,
Carrier, M. J.,
and Rosenberger, R. F.
(1991)
Nucleic Acids Res.
19,
3511-3516
|
| 35.
|
Kenyon, G. L.
(1996)
Nature
381,
281-282
|
| 36.
|
Page, M. I.,
and Jencks, W. P.
(1971)
Proc. Natl. Acad. Sci. U. S. A.
68,
1678-1683
|
| 37.
|
Storm, D. R.,
and Koshland, D. E., Jr.
(1970)
Proc. Natl. Acad. Sci. U. S. A.
66,
445-452
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. S. Pruett, A. Azzi, S. A. Clark, M. S. Yousef, J. L. Gattis, T. Somasundaram, W. R. Ellington, and M. S. Chapman
The Putative Catalytic Bases Have, at Most, an Accessory Role in the Mechanism of Arginine Kinase
J. Biol. Chem.,
July 11, 2003;
278(29):
26952 - 26957.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.